David Berd

5.5k total citations
118 papers, 4.4k citations indexed

About

David Berd is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, David Berd has authored 118 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Immunology, 55 papers in Oncology and 35 papers in Molecular Biology. Recurrent topics in David Berd's work include Immunotherapy and Immune Responses (61 papers), Cancer Immunotherapy and Biomarkers (27 papers) and Monoclonal and Polyclonal Antibodies Research (16 papers). David Berd is often cited by papers focused on Immunotherapy and Immune Responses (61 papers), Cancer Immunotherapy and Biomarkers (27 papers) and Monoclonal and Polyclonal Antibodies Research (16 papers). David Berd collaborates with scholars based in United States, Japan and Italy. David Berd's co-authors include Michael J. Mastrangelo, Henry Maguire, Takami Sato, Robert E. Bellet, Peter A. McCue, Carol L. Shields, Edmund C. Lattime, Jerry A. Shields, Gëorge F. Murphy and Faith E. Nathan and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

David Berd

115 papers receiving 4.1k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
David Berd 2.2k 2.2k 1.6k 437 386 118 4.4k
Christopher Schmidt 1.9k 0.9× 1.5k 0.7× 1.3k 0.8× 186 0.4× 402 1.0× 88 3.3k
Marina Fabbi 3.5k 1.6× 1.5k 0.7× 1.2k 0.8× 110 0.3× 286 0.7× 93 5.2k
Danielle Líénard 5.3k 2.4× 3.3k 1.5× 2.4k 1.5× 138 0.3× 291 0.8× 89 7.1k
Archana Thakur 947 0.4× 1.2k 0.6× 1.2k 0.7× 264 0.6× 362 0.9× 128 2.9k
Gregory Lizée 2.2k 1.0× 1.8k 0.8× 1.2k 0.8× 81 0.2× 157 0.4× 86 3.4k
Akio Matsuzawa 3.7k 1.7× 1.6k 0.7× 2.4k 1.5× 48 0.1× 455 1.2× 146 6.2k
Dale Porter 703 0.3× 1.4k 0.6× 2.5k 1.5× 108 0.2× 930 2.4× 51 4.1k
Thomas Wölfel 5.1k 2.3× 2.8k 1.3× 2.8k 1.7× 48 0.1× 233 0.6× 70 6.4k
Henrik Schmidt 1.8k 0.8× 2.6k 1.2× 1.1k 0.7× 60 0.1× 252 0.7× 96 3.6k
HP Koeffler 1.6k 0.7× 1.8k 0.8× 3.1k 1.9× 47 0.1× 550 1.4× 90 6.5k

Countries citing papers authored by David Berd

Since Specialization
Citations

This map shows the geographic impact of David Berd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Berd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Berd more than expected).

Fields of papers citing papers by David Berd

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Berd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Berd. The network helps show where David Berd may publish in the future.

Co-authorship network of co-authors of David Berd

This figure shows the co-authorship network connecting the top 25 collaborators of David Berd. A scholar is included among the top collaborators of David Berd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Berd. David Berd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Terai, Mizue, Masumi Eto, David Berd, et al.. (2011). Interleukin 6 mediates production of interleukin 10 in metastatic melanoma. Cancer Immunology Immunotherapy. 61(2). 145–155. 30 indexed citations
2.
Berger, Adam C., John C. Kairys, David Berd, et al.. (2011). Lymph node ratio is an important and independent prognostic factor for patients with stage III melanoma. Journal of Surgical Oncology. 105(1). 15–20. 13 indexed citations
3.
Mahipal, Amit, Mizue Terai, David Berd, et al.. (2011). Tumor-derived interleukin-10 as a prognostic factor in stage III patients undergoing adjuvant treatment with an autologous melanoma cell vaccine. Cancer Immunology Immunotherapy. 60(7). 1039–1045. 18 indexed citations
4.
Terai, Mizue, Yutaka Tamura, Vitali Alexeev, et al.. (2009). Human interleukin 10 receptor 1/IgG1-Fc fusion proteins: immunoadhesins for human IL-10 with therapeutic potential. Cancer Immunology Immunotherapy. 58(8). 1307–1317. 18 indexed citations
5.
Patel, Kashyap, Kevin L. Sullivan, David Berd, et al.. (2005). Chemoembolization of the hepatic artery with BCNU for metastatic uveal melanoma: results of a phase II study. Melanoma Research. 15(4). 297–304. 90 indexed citations
6.
Coss, Ronald A., Christopher Storck, Constantine Daskalakis, David Berd, & M Wahl. (2003). Intracellular acidification abrogates the heat shock response and compromises survival of human melanoma cells.. PubMed. 2(4). 383–8. 35 indexed citations
7.
Sato, Takami, et al.. (2003). Combination of monocyte-derived dendritic cells and activated T cells which express CD40 ligand: a new approach to cancer immunotherapy. Cancer Immunology Immunotherapy. 53(1). 53–61. 9 indexed citations
8.
Coss, Ronald A., Christopher Storck, Phyllis Wachsberger, et al.. (2003). Acute extracellular acidification reduces intracellular pH, 42°C-induction of heat shock proteins and clonal survival of human melanoma cells grown at pH 6.7. International Journal of Hyperthermia. 20(1). 93–106. 14 indexed citations
9.
Berd, David. (2003). Contribution of dead cells to the immunogenicity of an autologous, hapten-modified melanoma vaccine. Vaccine. 21(7-8). 795–797. 3 indexed citations
10.
Storck, Christopher, Phyllis Wachsberger, Dennis B. Leeper, et al.. (2002). Acute extracellular acidification increases nuclear associated protein levels in human melanoma cells during 42°C hyperthermia and enhances cell killing. International Journal of Hyperthermia. 18(5). 404–415. 7 indexed citations
11.
Manne, Jayanthi, Michael J. Mastrangelo, Takami Sato, & David Berd. (2002). TCR Rearrangement in Lymphocytes Infiltrating Melanoma Metastases After Administration of Autologous Dinitrophenyl-Modified Vaccine. The Journal of Immunology. 169(6). 3407–3412. 19 indexed citations
12.
Sensi, Marialuisa, Cinthia Farina, Cristina Maccalli, et al.. (1998). Intralesional Selection of T Cell Clonotypes in the Immune Response to Melanoma Antigens Occurring During Vaccination. Journal of Immunotherapy. 21(3). 198–204. 9 indexed citations
13.
Ohta, Masataka, David Berd, Masayoshi Shimizu, et al.. (1996). Deletion mapping of chromosome region 9p21‐p22 surrounding the CDKN2 locus in melanoma. International Journal of Cancer. 65(6). 762–767. 8 indexed citations
14.
Berd, David, et al.. (1996). Melanoma and vitiligo: immunology's Grecian urn. Cancer Immunology Immunotherapy. 42(5). 263–267. 23 indexed citations
15.
Ohta, Masataka, David Berd, Masayoshi Shimizu, et al.. (1996). Deletion mapping of chromosome region 9p21-p22 surrounding theCDKN2 locus in melanoma. International Journal of Cancer. 65(6). 762–767. 79 indexed citations
16.
Berd, David & Giorgio Parmiani. (1995). Human tumor vaccines go molecular. Cancer Immunology Immunotherapy. 41(3). 199–200. 1 indexed citations
17.
Cohen, I., Alan D. Murdoch, Michael Naso, et al.. (1994). Abnormal expression of perlecan proteoglycan in metastatic melanomas.. PubMed. 54(22). 5771–4. 107 indexed citations
18.
Berd, David, Henry Maguire, Michael J. Mastrangelo, & Gëorge F. Murphy. (1994). Activation markers on T cells infiltrating melanoma metastases after therapy with dinitrophenyl-conjugated vaccine. Cancer Immunology Immunotherapy. 39(3). 141–147. 29 indexed citations
19.
McLean, Ian W., David Berd, Michael J. Mastrangelo, et al.. (1990). A Randomized Study of Methanol-Extraction Residue of Bacille Calmette-Guerin as Postsurgical Adjuvant Therapy of Uveal Melanoma. American Journal of Ophthalmology. 110(5). 522–526. 36 indexed citations
20.
Berd, David. (1978). Effects of Corynebacterium parvum on immunity. 2(2). 373–395. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christopher Schmidt Breakdown of academic impact, for papers by Marina Fabbi Breakdown of academic impact, for papers by Danielle Líénard Breakdown of academic impact, for papers by Archana Thakur Breakdown of academic impact, for papers by Gregory Lizée Breakdown of academic impact, for papers by Akio Matsuzawa Breakdown of academic impact, for papers by Dale Porter Breakdown of academic impact, for papers by Thomas Wölfel Breakdown of academic impact, for papers by Henrik Schmidt Breakdown of academic impact, for papers by HP Koeffler
Rankless by CCL
2026